BeOne Medicines (ONC) Change in Inventory (2017 - 2026)

BeOne Medicines (ONC) has 10 years of Change in Inventory data on file, last reported at $71.8 million in Q1 2026.

• Quarterly Change in Inventory rose 1901.81% year-over-year to $71.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $169.0 million (up 236.34% YoY) and the FY2025 annual result came in at $93.2 million, up 1.83% from the prior year.
• Change in Inventory advanced to $71.8 million in Q1 2026 per ONC's latest filing, from $70.5 million in the prior quarter.
• Across five years, Change in Inventory topped out at $88.6 million in Q4 2023 and bottomed at -$23.8 million in Q3 2024.
• The 5-year median for Change in Inventory is $28.6 million (2022), against an average of $26.7 million.
• The widest annual swing landed in 2024, when Change in Inventory tumbled 1842.71%; it then soared 1901.81% in 2026.
• Tracing ONC's Change in Inventory over 5 years: stood at -$18.9 million in 2022, then soared by 567.6% to $88.6 million in 2023, then decreased by 10.38% to $79.4 million in 2024, then retreated by 11.18% to $70.5 million in 2025, then advanced by 1.89% to $71.8 million in 2026.
• Per Business Quant, the three latest ONC Change in Inventory figures stand at $71.8 million (Q1 2026), $70.5 million (Q4 2025), and $28.8 million (Q3 2025).

Peer Comparison